DR REDDYS LABORATORIES
Back to All Ratios
|
DR REDDYS LABORATORIES Last 5 Year Price to Cash Earnings (PCE) History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| PCE(x) | 16.85 | 12.84 | 14.57 | 13.37 | 21.40 |
What is the latest Price to Cash Earnings (PCE) ratio of DR REDDYS LABORATORIES ?
| Year | Price to Cash Earnings (PCE) |
|---|---|
| Mar2026 | 16.85 |
| Mar2025 | 12.84 |
| Mar2024 | 14.57 |
| Mar2023 | 13.37 |
| Mar2022 | 21.40 |
How is Price to Cash Earnings (PCE) of DR REDDYS LABORATORIES Trending?
| Years | Price to Cash Earnings (PCE) | % Change | |
|---|---|---|---|
| Mar2026 | 16.85 | 31.23 | |
| Mar2025 | 12.84 | -11.87 | |
| Mar2024 | 14.57 | 8.98 | |
| Mar2023 | 13.37 | -37.52 | |
| Mar2022 | 21.4 | - | |
Other Financial Ratios of DR REDDYS LABORATORIES
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Price to Cash Earnings (PCE) ratio of peers of DR REDDYS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR REDDYS LABORATORIES | ₹115,020.8 Cr | 0.6% | 13.4% | 15.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,291.0 Cr | -1.8% | 7.6% | 11.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹305,014.0 Cr | 3.7% | 27.2% | 71.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,333.0 Cr | -2.3% | 1.5% | 23.6% | Stock Analytics | |
| CIPLA | ₹112,539.0 Cr | -1.3% | 6.1% | -6.9% | Stock Analytics | |
| MANKIND PHARMA | ₹109,622.0 Cr | 3% | 13.9% | 17.8% | Stock Analytics | |
DR REDDYS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR REDDYS LABORATORIES | 0.6% |
13.4% |
15.7% |
| SENSEX | 0.7% |
11.7% |
-2% |
You may also like the below Video Courses